Cargando…

A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia

Objective: The study aimed to thoroughly address the influence of benzbromarone and allopurinol on the risk of the development of type 2 diabetes mellitus (T2DM) in people with asymptomatic hyperuricemia. Methods: We conducted a retrospective cohort study to examine the 2000–2015 national dataset co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Shih-Wei, Liao, Kuan-Fu, Kuo, Yu-Hung, Lin, Cheng-Li, Liu, Chiu-Shong, Hwang, Bing-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514696/ https://www.ncbi.nlm.nih.gov/pubmed/34658871 http://dx.doi.org/10.3389/fphar.2021.731370

Ejemplares similares

Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022)

The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Allopurinol Use and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of Cohort Studies
por: Lai, Shih-Wei, et al.
Publicado: (2022)

A meta-analysis of allopurinol therapy and the risk of prostate cancer
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Allopurinol use and the risk of dementia: A meta-analysis of case–control studies
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021)

Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022)

Sex differences in response to allopurinol and benzbromarone in gout: a retrospective cohort study
por: Veenstra, Frouwke, et al.
Publicado: (2021)

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014)

Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia
por: Chen, Xiaolin, et al.
Publicado: (2020)

Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone
por: Niu, Sheng-Wen, et al.
Publicado: (2022)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

The incidence of herpes zoster in patients with diabetes mellitus: A meta-analysis of cohort studies
por: Lai, Shih-Wei, et al.
Publicado: (2021)

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Allopurinol use associated with increased risk of acute myocardial infarction in older people in a case–control study
por: Liao, Kuan-Fu, et al.
Publicado: (2019)

Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Quantitative Estimation of Urate Transport in Nephrons in Relation to Urinary Excretion Employing Benzbromarone-Loading Urate Clearance Tests in Cases of Hyperuricemia
por: Nakamura, Toru, et al.
Publicado: (2011)

Commentary on: The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
por: Nasri, Hamid
Publicado: (2013)

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
por: Liao, Zhimin, et al.
Publicado: (2022)

Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
por: Zhang, Lin, et al.
Publicado: (2022)

Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study
por: Alghamdi, Youssef Saeed, et al.
Publicado: (2020)

Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia
por: Sung, Yoon-Young, et al.
Publicado: (2022)

The incidence rate of herpes zoster in inflammatory bowel disease: A meta-analysis of cohort studies
por: Lai, Shih-Wei, et al.
Publicado: (2021)

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
por: Guan, Xudong, et al.
Publicado: (2022)

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
por: Li, Yanchun, et al.
Publicado: (2019)

Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation
por: López, Laura C., et al.
Publicado: (2016)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
por: Kim, Sollip, et al.
Publicado: (2017)

Integrative metabolomic and network pharmacological analysis reveals potential mechanisms of Cardamine circaeoides Hook.f. & Thomson in alleviating potassium oxonate-induced asymptomatic hyperuricemia in rats
por: Zhu, Yingli, et al.
Publicado: (2023)

The EYA Tyrosine Phosphatase Activity Is Pro-Angiogenic and Is Inhibited by Benzbromarone
por: Tadjuidje, Emmanuel, et al.
Publicado: (2012)

Benzbromarone Stabilizes ΔF508 CFTR at the Cell Surface
por: Loo, Tip W., et al.
Publicado: (2011)

Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Li, Zhaoliang, et al.
Publicado: (2019)

Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis
por: Liu, Hongyan, et al.
Publicado: (2023)

Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study
por: Wang, Chun-Yi, et al.
Publicado: (2022)

The Curious Case of Benzbromarone: Insight into Super-Inhibition of Cytochrome P450
por: Parashar, Abhinav, et al.
Publicado: (2014)

Liver failure associated with benzbromarone: A case report and review of the literature
por: Zhang, Ming-Yuan, et al.
Publicado: (2019)

Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans
por: Mujwar, Somdutt, et al.
Publicado: (2022)

HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
por: Sukasem, Chonlaphat, et al.
Publicado: (2016)

Comparison of efficacy and safety between febuxostat and allopurinol in early post‐renal transplant recipients with new onset of hyperuricemia
por: Shen, Xiaoju, et al.
Publicado: (2018)

Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles—Results from a Population-Based PolSenior Study
por: Winder, Mateusz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9inghd19ttefdb6dbhfroc66ua